Indeed, insulin resistance is an increasingly relevant risk factor of PD [40], and administration of insulin has been reported to alleviate cognitive impairment in a 6-OHDA-induced PD model through reducing the levels of p-AKT and p-GSK3β [41]. The gene discussed is GSK3B; the disease is Cognitive impairment.